| Literature DB >> 24731404 |
Paul E Goss1, Kathrin Strasser-Weippl2, Brittany L Lee-Bychkovsky3, Lei Fan4, Junjie Li4, Yanin Chavarri-Guerra5, Pedro E R Liedke6, C S Pramesh7, Tanja Badovinac-Crnjevic8, Yuri Sheikine9, Zhu Chen10, You-lin Qiao11, Zhiming Shao12, Yi-Long Wu13, Daiming Fan14, Louis W C Chow15, Jun Wang16, Qiong Zhang17, Shiying Yu18, Gordon Shen19, Jie He20, Arnie Purushotham21, Richard Sullivan22, Rajendra Badwe23, Shripad D Banavali24, Reena Nair25, Lalit Kumar26, Purvish Parikh27, Somasundarum Subramanian28, Pankaj Chaturvedi29, Subramania Iyer30, Surendra Srinivas Shastri31, Raghunadhrao Digumarti32, Enrique Soto-Perez-de-Celis33, Dauren Adilbay34, Vladimir Semiglazov35, Sergey Orlov36, Dilyara Kaidarova37, Ilya Tsimafeyeu38, Sergei Tatishchev39, Kirill D Danishevskiy40, Marc Hurlbert41, Caroline Vail42, Jessica St Louis42, Arlene Chan43.
Abstract
Cancer is one of the major non-communicable diseases posing a threat to world health. Unfortunately, improvements in socioeconomic conditions are usually associated with increased cancer incidence. In this Commission, we focus on China, India, and Russia, which share rapidly rising cancer incidence and have cancer mortality rates that are nearly twice as high as in the UK or the USA, vast geographies, growing economies, ageing populations, increasingly westernised lifestyles, relatively disenfranchised subpopulations, serious contamination of the environment, and uncontrolled cancer-causing communicable infections. We describe the overall state of health and cancer control in each country and additional specific issues for consideration: for China, access to care, contamination of the environment, and cancer fatalism and traditional medicine; for India, affordability of care, provision of adequate health personnel, and sociocultural barriers to cancer control; and for Russia, monitoring of the burden of cancer, societal attitudes towards cancer prevention, effects of inequitable treatment and access to medicine, and a need for improved international engagement.Entities:
Mesh:
Year: 2014 PMID: 24731404 DOI: 10.1016/S1470-2045(14)70029-4
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316